ストックスクリーナーアプリを入手
19.76
1.72%
-0.345
Sionna Therapeutics Inc (SION) 最新ニュース
Atlas Venture Fund Xi L.P Reports 6.5% Stake In Sionna Therapeutics As Of Feb 10 - Marketscreener.com
The Surprising Stock Insiders Can’t Stop Buying: What’s the Hype? - MotoPaddock
Sionna Therapeutics: The Biotech Stock Insiders Are Snapping Up! - Smartphone Magazine
Sionna Therapeutics: The Under-the-Radar Insider Favorite You’ve Been Missing - Anexartiti
Biopharma Gamble: Why Insiders Are Betting Big on Sionna Therapeutics - dsa.si
Why Insiders Are Betting Big on Sionna Therapeutics This Year - Bit Perfect Solutions
The Biopharma Gamble: Why Insiders Are Banking on Sionna Therapeutics - Elblog.pl
Is Sionna Therapeutics (SION) Among Stocks Insiders Are Buying This Year? - Yahoo Finance
Sionna therapeutics sees $20.25 million stock purchase by TPG - MSN
Sionna Therapeutics’ $219.2 Million Upsized IPO - Global Legal Chronicle
Major Stock Acquisition Signals Confidence in Sionna Therapeutics - TipRanks
Sionna Therapeutics updates corporate bylaws post-IPO - Investing.com India
Sionna Therapeutics updates corporate bylaws post-IPO By Investing.com - Investing.com Australia
Major Stakeholders Make Bold Moves on Sionna Therapeutics Stock! - TipRanks
Ra capital management acquires $20.25m in Sionna Therapeutics stock By Investing.com - Investing.com Australia
Ra capital management acquires $20.25m in Sionna Therapeutics stock - Investing.com India
Orbimed advisors buys $9.9 million in Sionna Therapeutics stock - Investing.com
Orbimed advisors buys $9.9 million in Sionna Therapeutics stock By Investing.com - Investing.com South Africa
Sionna Therapeutics director Peter Thompson acquires $9.9m in IPO shares - Investing.com Nigeria
Sionna Therapeutics, Inc. Completes Upsized IPO Raising Approximately $219.2 Million to Advance Cystic Fibrosis Treatments - Nasdaq
Sionna Therapeutics Announces Closing of $219.2 million - GlobeNewswire
Sionna Therapeutics Announces Closing of $219.2 million Upsized Initial Public Offering, Including Full Exercise of Underwriters' Option to Purchase Additional Shares - Benzinga
Cystic Fibrosis Biotech Startup Secures Massive $219M War Chest in Oversubscribed Nasdaq Debut - StockTitan
Share in cystic fibrosis firm Sionna rise sharply after IPO - pharmaphorum
🔬 Latest pharma industry updates 👇 - substack.com
Vertex Pharma Challenger Sionna Secures $191M in IPO Cash for Cystic Fibrosis Pipeline - MedCity News
Sionna Therapeutics Inc. (SION): RA Capital Backed Biotech IPO Booms in Debut - Smartkarma
Cystic fibrosis drug developer Sionna rises on trading debut - MSN
Strong demand for Sionna latest good sign for IPOs: Public Equity Report - BioCentury
Sionna IPO Grosses $191m To Compete With Vertex In CF - News & Insights
Opening Day: Sionna Therapeutics, Titan America make public debut - TipRanks
Arrowhead appoints Douglas Ingram as new director - MSN
Sionna Therapeutics prices upsized IPO at $18 per share - MSN
Sionna stock rises on trading debut (SION:NASDAQ) - Seeking Alpha
Cystic fibrosis drug developer raises $191M in first Mass. IPO of 2025 - The Business Journals
Sionna goes public in $135M IPO, Aardvark plots $103M listing - Fierce Biotech
Sionna Therapeutics set to open nearly 40% above offer price after upsized $191 mln IPO - TradingView
Sionna Therapeutics Inc. (SION): Biotech Guiding to High-End Pricing; Expecting Strong Outcome - Smartkarma
Goodwin, Ropes Lead Cystic Fibrosis Co.'s Upsized $191M IPO - Law360
ForexTV | Small Business Resources - ForexTV.com
Vertex challenger Sionna prices $191M IPO - BioPharma Dive
Sionna Therapeutics, Inc IPOs Tomorrow, Here's What You Need To Know - Benzinga
Sionna Therapeutics Inc. Prices Upsized Initial Public Offering at $18.00 per Share - Nasdaq
Vera started at buy by Goldman Sachs, atacicept potential cited - MSN
Cystic fibrosis company Sionna seeks $150 million raise in IPO - The Pharma Letter
Major Breakthrough in Cystic Fibrosis Treatment: Sionna Therapeutics Sets Sights on IPO Success - mivalle.net.ar
Waltham biotech plans to raise $150M in IPO this week - The Business Journals
L’Oreal to Sell $3.1 Billion Stake in Sanofi Back to Pharma Group - MSN
Sionna Therapeutics, Inc. (SION): Phase I Cystic Fibrosis Biotech Sets Terms for IPO - Smartkarma
Sionna Therapeutics Set to Make Waves with $150 Million IPO! - Mi Valle
Biotech firm Maze Therapeutics raises $140 million in US IPO - MSN
Ascentage lists on NASDAQ as Odyssey, Sionna, Aardvark plot IPOs - BioCentury
Sionna Therapeutics Seeks $100 Million in IPO For Cystic Fibrosis Treatments - Seeking Alpha
Modest Final Quarter Completes Shaky Biotech IPO Comeback For 2024 - News & Insights
Sionna, cystic fibrosis drug developer, files for $100M IPO - MSN
Sionna Therapeutics, Inc. (SION): Biotech for Patients with Cystic Fibrosis Filed for IPO - Smartkarma
Two more biotechs join IPO waiting list - pharmaphorum
SION IPO NewsCystic fibrosis biotech Sionna Therapeutics files for a $100 million IPO - Renaissance Capital
Testing of Sionna’s NBD1 stabilizers for CF begins in healthy volunteers - Cystic Fibrosis News Today
Pipeline power: Sionna’s AbbVie deal could redefine CF therapeutics - Pharmaceutical Technology
Sionna revives AbbVie’s cystic fibrosis drugs, eyeing a shot at Vertex - BioPharma Dive
0.27%
3.05%
大文字化:
|
ボリューム (24 時間):